国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2010年
9期
710-712
,共3页
黄引芳%傅深%章青%邵雨卉
黃引芳%傅深%章青%邵雨卉
황인방%부심%장청%소우훼
白细胞介素-11%头颈部肿瘤%放射疗法%口腔黏膜反应
白細胞介素-11%頭頸部腫瘤%放射療法%口腔黏膜反應
백세포개소-11%두경부종류%방사요법%구강점막반응
Interleukin-11%Head and neck neoplasms%Radiotherapy%Oral mucosal reaction
目的 探讨预防和治疗头颈部肿瘤放疗性口腔黏膜反应的有效方法.方法 对2008年3月至2010年3月间50例头颈部肿瘤放疗患者随机分组对照观察.在放射治疗期间,观察组给予白细胞介素-11(IL-11)局部雾化吸入,对照组未给予IL-11.结果 观察组患者对IL-11耐受性良好,并在降低口腔黏膜反应程度、减轻疼痛和增进患者食欲等方面效果显著(P<0.05).患者的疼痛时间由对照组的4.5 d±1.3 d减为观察组的2.3 d±1.0 d,愈合时间由对照组的7.3 d±1.5 d减为观察组的4.1 d±1.7 d,差异有统计学意义(P<0.05).结论 IL-11对预防和治疗头颈部肿瘤放疗性口腔黏膜反应有显著疗效,可减轻放疗性口腔黏膜反应给患者带来的痛苦,提高了生活质量.
目的 探討預防和治療頭頸部腫瘤放療性口腔黏膜反應的有效方法.方法 對2008年3月至2010年3月間50例頭頸部腫瘤放療患者隨機分組對照觀察.在放射治療期間,觀察組給予白細胞介素-11(IL-11)跼部霧化吸入,對照組未給予IL-11.結果 觀察組患者對IL-11耐受性良好,併在降低口腔黏膜反應程度、減輕疼痛和增進患者食欲等方麵效果顯著(P<0.05).患者的疼痛時間由對照組的4.5 d±1.3 d減為觀察組的2.3 d±1.0 d,愈閤時間由對照組的7.3 d±1.5 d減為觀察組的4.1 d±1.7 d,差異有統計學意義(P<0.05).結論 IL-11對預防和治療頭頸部腫瘤放療性口腔黏膜反應有顯著療效,可減輕放療性口腔黏膜反應給患者帶來的痛苦,提高瞭生活質量.
목적 탐토예방화치료두경부종류방료성구강점막반응적유효방법.방법 대2008년3월지2010년3월간50례두경부종류방료환자수궤분조대조관찰.재방사치료기간,관찰조급여백세포개소-11(IL-11)국부무화흡입,대조조미급여IL-11.결과 관찰조환자대IL-11내수성량호,병재강저구강점막반응정도、감경동통화증진환자식욕등방면효과현저(P<0.05).환자적동통시간유대조조적4.5 d±1.3 d감위관찰조적2.3 d±1.0 d,유합시간유대조조적7.3 d±1.5 d감위관찰조적4.1 d±1.7 d,차이유통계학의의(P<0.05).결론 IL-11대예방화치료두경부종류방료성구강점막반응유현저료효,가감경방료성구강점막반응급환자대래적통고,제고료생활질량.
Objective To explore an effective method for preventing and treating oral mucosal complications of radiotherapy for head and neck cancer. Methods Fifty head and neck cancer patients who were receiving radiotherapy were enrolled between March, 2008 and March, 2010. These patients were randomly assigned to the treatment group and the control group. During the radiotherapy, patients in the treatment group were given IL-11 in the form of atomization inhalation,whereas patients in the control group were not. Results IL-1 1 was well tolerated by the patients. It significantly decreased the level of oral mucosal complications and pains and improved patients' appetites ( P < 0.05 ). In addition, the duration of pain was significantly ( P <0.05 ) reduced from 4.5 ± 1.3 days ( in control group) to 2.3 ± 1.0 ( in treatment group), and the healing period was also significantly ( P < 0.05) reduced from 7.3 ± 1.5 days ( in control group) to 4.1 ± 1.7 ( in treatment group). Conclusion IL-11 is effective in preventing and treating oral mucosal complications of radiotherapy for head and neck cancer,relieving associated pains, and therefore improving patients' quality of life.